The WACC of China Health Industries Holdings Inc (CHHE) is 4.2%.
Range | Selected | |
Cost of equity | 23549.2% - 36551.7% | 30050.45% |
Tax rate | 17.9% - 29.3% | 23.6% |
Cost of debt | 5.0% - 5.0% | 5% |
WACC | 4.4% - 4.0% | 4.2% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 5118.55 | 6526.22 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 23549.2% | 36551.7% |
Tax rate | 17.9% | 29.3% |
Debt/Equity ratio | 78639.3 | 78639.3 |
Cost of debt | 5.0% | 5.0% |
After-tax WACC | 4.4% | 4.0% |
Selected WACC | 4.2% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
CHHE | China Health Industries Holdings Inc | 78639.3 | 0.4 | 0 |
CAWW | CCA Industries Inc | 0.12 | 1.06 | 0.97 |
EMPO | Empowered Products Inc | 0.14 | 0 | 0 |
EVE.V | Eve & Co Inc | 5.29 | 0.89 | 0.19 |
FTLF | FitLife Brands Inc | 0.1 | 0.9 | 0.84 |
GBLP | Global Pharmatech Inc | 0.03 | 0.17 | 0.17 |
GENX.V | GenixPharmaceucticals Corporation | 0.51 | 0.22 | 0.16 |
SPCO | Stephan Co | 0.04 | 0.1 | 0.1 |
SXTC | China SXT Pharmaceuticals Inc | 0.01 | 0.46 | 0.45 |
Low | High | |
Unlevered beta | 0.16 | 0.18 |
Relevered beta | 7639.13 | 9740.13 |
Adjusted relevered beta | 5118.55 | 6526.22 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for CHHE:
cost_of_equity (30,050.45%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (5118.55) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.